How Are Peptides Absorbed? SubQ, Intranasal, and Oral Bioavailability
The same molecule can differ by orders of magnitude in exposure depending on the route. Understanding routes is the key to understanding “why research mostly uses injections”.
Route Comparison
Section titled “Route Comparison”| Route | Characteristics | Common scenarios | Limitations |
|---|---|---|---|
| Subcutaneous injection (SubQ) | Relatively controllable absorption | Most peptide research | Invasive; technique barrier |
| Intramuscular injection (IM) | Used for some preparations | A few protein drugs | Irritation, pain |
| Intranasal spray | Avoids hepatic first-pass; common in CNS-related research | Semax/Selank, etc. | Nasal mucosal barrier; dose variability |
| Oral (enteric-coated) | Good adherence | Some small / modified peptides | Proteolytic degradation; first-pass effect |
| Topical / microneedle | Local, skin-layer | Cosmetic peptides | Limited transdermal delivery |
Why Most Peptides Cannot Be Taken Orally
Section titled “Why Most Peptides Cannot Be Taken Orally”- Enzymatic digestion: pepsin and pancreatic enzymes rapidly cleave peptide bonds.
- First-pass effect: hepatic metabolism.
- Molecular weight and charge: passive absorption is limited.
Research peptides are therefore mostly delivered by injection or intranasal spray; oral peptides are usually di-/tripeptides, cyclized or modified peptides, or use specialized delivery.
“Transdermal” Delivery of Cosmetic Peptides
Section titled ““Transdermal” Delivery of Cosmetic Peptides”Palmitoyl / myristoyl modification increases lipid solubility and is a common strategy for cosmetic peptides; transdermal depth correlates strongly with concentration and the delivery vehicle (liposomes, microneedles).
Dosage Forms and Delivery, Explained
Section titled “Dosage Forms and Delivery, Explained”Switching the dosage form of the same molecule can change exposure by a wide margin, usually because of the delivery step rather than the molecule itself.
- Enteric coating: bypasses gastric acid and some proteases, moving the release point downstream to the intestine.
- Liposomes and nanocarriers: change membrane interaction and stability; carrier composition affects transdermal delivery and release.
- Microneedles and permeation enhancement: physically open channels through the stratum corneum, commonly used for local delivery of cosmetic peptides.
- Modification strategies: cyclization, fatty-acid modification, and non-natural amino acids all aim to improve proteolytic stability and half-life.
Dosage-form differences directly rewrite comparability across the literature: results for the same named molecule in different carriers should not be compared head-to-head, and when a paper does not state the carrier and process, readings should be more conservative. In reading order, establish which dosage form and route a study used before discussing exposure and outcomes — reversing that order invites misreading. The classification entry point is Peptide Basics; ingredient context can be read against weight and metabolism peptides and sports recovery peptides.
Route Selection Principles
Section titled “Route Selection Principles”For research peptides, prefer SubQ or intranasal; for cosmetic peptides, look at the transdermal system; oral delivery depends on modification and delivery technology.
| Question | Go to |
|---|---|
| How to set the concentration | Reconstitution & Conversion |
| How to store | Storage & Stability |
| How to judge quality | COA Explained |
Entry cross-reference: Cosmeceutical Peptides, Oral Oligopeptides.
Safety Boundaries and Limitations
Section titled “Safety Boundaries and Limitations”Bioavailability is affected by formulation and individual differences; published PK data cannot be extrapolated directly. Route comparisons are for understanding mechanisms, not for guiding dosing decisions.
Key References
Section titled “Key References”For transdermal measurement challenges see PMID: 39795193; AH-8 transdermal delivery PMID: 24754410.
What to Read Next?
Section titled “What to Read Next?”Combine the mechanisms on this page with the ingredient entries and the practical guides for cross-reference.
Related Reading
Section titled “Related Reading”Why Can’t Most Peptides Be Taken Orally?
Section titled “Why Can’t Most Peptides Be Taken Orally?”Gastrointestinal enzymatic digestion and hepatic first-pass metabolism; small or modified peptides are exceptions — see Oral Oligopeptides.